After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Johnson & Johnson is listed on the NYSE as a member of the Healthcare sector and is a part of the Drug Manufacturers – General industry. The current market capitalization of Johnson & Johnson is $480.85B. A total of 12.87 million shares were traded on the day, compared to an average of 8.29M shares.
In the most recent transaction, JOHNSON & JOHNSON sold 1,000 shares of JNJ for 10.00 per share on Nov 12 ’25. After the transaction, the 10% Owner now owns 4,049,898 company shares. In a previous transaction on Nov 06 ’25, JOHNSON & JOHNSON sold 52,332 shares at 10.21 per share. JNJ shares that 10% Owner owns now total 4,051,098.
Among the insiders who sold shares, JOHNSON & JOHNSON disposed of 200 shares on Nov 07 ’25 at a per-share price of $10.00. This resulted in the 10% Owner holding 4,050,898 shares of JNJ after the transaction. In another insider transaction, REED JOHN C sold 21,721 shares at $192.71 per share on Oct 17 ’25. Company shares held by the EVP, Innovative Medicine, R&D now total 10,658.
Dividend
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Johnson & Johnson pays an annual dividend of $5.08, resulting in a dividend yield of 2.55%, and it has a price to earnings (P/E) ratio of 19.26.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, JNJ has a high of $197.18 and a low of $140.68.
As of this writing, JNJ has an earnings estimate of $2.53 per share for the current quarter. EPS was calculated based on a consensus of 18.0 estimates, with a high estimate of $2.58 per share and a lower estimate of $2.47. The company reported an EPS of $2.04 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. JNJ’s latest balance sheet shows that the firm has $31.61B in Cash & Short Term Investments as of fiscal 2021. There were $33.75B in debt and $45.23B in liabilities at the time. Its Book Value Per Share was $32.95, while its Total Shareholder’s Equity was $74.02B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JNJ is Buy with a score of 4.15.
